To further investigate the improved CD8+ responses, we used the 1A9 mAb (15) to detect processing and presentation on MDDCs of the melanoma gp100 Class I peptide gp100 209-217 in the context of cell surface HLA-A2. Here, CD8A is linked to melanoma.